U.S. federal trademark · Serial No. 86456221 · Reg. No. TMA1057615
Oncolytic viruses, namely, oncolytic vaccines, viral vectors for gene delivery or protein expression from the gene; pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases; pharmaceutical and vaccine products in the field of cancer and infectious diseases
Research and development in connection with oncolytic viruses and oncolytic vaccines, viral vectors; pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases; pharmaceutical and vaccine products in the field of cancer and infectious disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.